tiprankstipranks
Trending News
More News >
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market

Rein Therapeutics (RNTX) Technical Analysis

Compare
1,195 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Neutral
5Bullish
1Neutral
4Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Rein Therapeutics’s (RNTX) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting Rein Therapeutics is a Sell.
Rein Therapeutics’s (RNTX) 20-Day exponential moving average is 1.90, while Rein Therapeutics’s (RNTX) share price is $2.21, making it a Buy.
Rein Therapeutics’s (RNTX) 50-Day exponential moving average is 1.89, while Rein Therapeutics’s (RNTX) share price is $2.21, making it a Buy.

Rein Therapeutics (RNTX) Pivot Points

May 17, 2025, 10:18 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.84
1.96
2.16
2.28
2.48
2.60
2.80
Fibonacci
1.96
2.08
2.16
2.28
2.40
2.48
2.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rein Therapeutics (RNTX) Moving Averages

May 17, 2025, 10:18 AM
Period
Simple
Exponential
MA5
2.12Buy
2.13Buy
MA10
1.92Buy
2.01Buy
MA20
1.86Buy
1.90Buy
MA50
1.82Buy
1.89Buy
MA100
1.99Buy
2.05Buy
MA200
2.45Sell
2.39Sell
Rein Therapeutics’s (RNTX) 10-Day exponential moving average is 2.01, while Rein Therapeutics’s (RNTX) share price is $2.21, making it a Buy.
Rein Therapeutics’s (RNTX) 100-Day exponential moving average is 2.05, while Rein Therapeutics’s (RNTX) share price is $2.21, making it a Buy.
Rein Therapeutics’s (RNTX) stock price is $2.21 and Rein Therapeutics’s (RNTX) 50-day simple moving average is 1.81, creating a Buy signal.
Rein Therapeutics’s (RNTX) stock price is $2.21 and Rein Therapeutics’s (RNTX) 100-day simple moving average is 1.99, creating a Buy signal.
Rein Therapeutics’s (RNTX) stock price is $2.21 and Rein Therapeutics’s (RNTX) 200-day simple moving average is 2.45, creating a Sell signal.

Rein Therapeutics (RNTX) Technical Indicators

May 17, 2025, 10:18 AM
Name
Value
Implied Action
RSI (14)
62.92
Neutral
STOCH (9,6)
89.96
Sell
STOCHRSI (14)
90.94
Sell
MACD (12,26)
0.10
Sell
ADX (14)
17.45
Buy
Williams %R
-21.35
Buy
CCI (14)
216.63
Sell
ATR (14)
0.21
-
Ultimate Oscillator
72.42
Buy
ROC
25.57
Buy
Rein Therapeutics’s (RNTX) Relative Strength Index (RSI) is 62.92, creating a Neutral signal.
Rein Therapeutics’s (RNTX) Trend Strength Indicator (ADX) is 17.45, creating a Buy signal.
Rein Therapeutics’s (RNTX) Commodity Channel Index (CCI) is 216.63, creating a Sell signal.
Rein Therapeutics’s (RNTX) Price Rate of Change (ROC) is 25.57, creating a Buy signal.

FAQ

Is RNTX a Buy, Hold, or Sell?
Based on RNTX’s technical indicators, RNTX is a Buy.
    What is RNTX’s RSI (14)?
    RNTX’s RSI (14) is 62.92, which suggests RNTX is a Neutral.
      What is RNTX’s MACD?
      RNTX’s MACD is 0.10, which suggests RNTX is a Sell.
        What is RNTX’s 5-day moving average?
        RNTX’s 5-day moving average is 2.12, which suggests RNTX is a Buy.
          What is RNTX’s 20-day moving average?
          RNTX 20-day moving average is 1.86, which suggests RNTX is a Buy.
            What is RNTX’s 50-day moving average?
            RNTX’s 50-day moving average is 1.81, which suggests RNTX is a Buy.
              What is RNTX’s 200-day moving average?
              RNTX’s 200-day moving average is 2.45, which suggests RNTX is a Sell.
                What is RNTX’s Williams % R (14)?
                RNTX’s Williams % R (14) is -21.35, which suggests RNTX is a Buy.
                  What is RNTX’s CCI (14)?
                  RNTX’s CCI (14) is 216.63, which suggests RNTX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis